
Graham Collins, MBBS, on New Agents, Prognostic Models in Hodgkin Lymphoma
The HemOnc Pulse
00:00
Hodgkin Lymphoma at Ash - What's the Latest Big Trial?
There's a lot of things that I've seen across the wires about Hodgkin lymphoma at Ash. But our goal is to highlight to listeners a little bit more of the ones that are clinically relevant, really important and maybe things that's really got your interest. And that's what we're going to talk about today. The first thing that peaked my interest was the HD21 trial.
Transcript
Play full episode